/newsroom/taxonomy/term/8592/all en /newsroom/channels/news/mcgill-university-and-moderna-expand-collaborations-new-projects-lipid-nanoparticle-research-349107 <p>ƽÌØÎå²»ÖÐ today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.</p> Tue, 18 Jul 2023 13:25:38 +0000 claire.loewen@mcgill.ca 306289 at /newsroom /newsroom/channels/news/experts-quebec-use-hpv-test-screen-cervical-cancer-replacing-pap-test-339732 <p>Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. Earlier this year, the Institut national d’excellence en santé et en services sociaux reported that the HPV test is more sensitive than a Pap smear and could allow patients to collect their own test samples.</p> Wed, 01 Jun 2022 17:15:40 +0000 frederique.mazerolle@mcgill.ca 288169 at /newsroom /newsroom/lucy-gilbert Thu, 29 Apr 2021 16:20:20 +0000 frederique.mazerolle@mcgill.ca 262048 at /newsroom /newsroom/channels/news/encouraging-results-patients-aggressive-brain-cancer-267254 <p>Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.</p> Thu, 23 Mar 2017 17:33:26 +0000 priya.pajel@mail.mcgill.ca 26806 at /newsroom /newsroom/channels/news/adverse-effects-and-incretin-based-drugs-diabetes-261900 <p><a href="/newsroom"><strong><em>ƽÌØÎå²»ÖÐ Newsroom</em></strong></a></p> <p><em>Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease</em></p> Mon, 01 Aug 2016 14:19:07 +0000 nima.adibpour@mail.mcgill.ca 26046 at /newsroom